In contrast, prolactin (PRL) has been found to enhance NK cell-mediated cytotoxicity in cervical cancer through the NKG2D/NKG2DL axis, which may counterbalance the effects of estrogen 171. This evidence concerns the gene PRL and cervical carcinoma.